ArticleOncoTargets and therapy2020

miR-381 Mediates the Development of Head and Neck Squamous Cell Carcinoma via Targeting STC2.

Hai-Feng Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.